Ownership and insider activity for Plus Therapeutics, Inc. (PSTV): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and individuals with other serious illnesses.
Price
| Price | $3.87 |
| Market Cap | $9M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-01 | ANDREWS RONALD ASBURY | M-Exempt | 922 | |
| 2026-07-01 | Guse Kyle | M-Exempt | 922 | |
| 2026-07-01 | ANDREWS RONALD ASBURY | M-Exempt | 922 | |
| 2026-07-01 | Guse Kyle | M-Exempt | 922 | |
| 2026-07-01 | van Es-Johansson An | M-Exempt | 922 | |
| 2026-07-01 | van Es-Johansson An | M-Exempt | 922 | |
| 2026-07-01 | HEDRICK MARC H | M-Exempt | 6,387 | |
| 2026-07-01 | HEDRICK MARC H | M-Exempt | 8,066 | |
| 2026-07-01 | HEDRICK MARC H | M-Exempt | 1,986 | |
| 2026-07-01 | HEDRICK MARC H | M-Exempt | 1,986 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12.6M | $9.6M | $5.3M | $17.6M | $8.3M | $18.4M | $18.1M | $8.6M | $76000 | $8.8M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.5M | 0 |
| Receivables | $1.3M | $257000 | $233000 | $1.3M | $59000 | $7000 | 0 | 0 | $571000 | 0 |
| Inventory | $3.7M | $3.2M | $107000 | $107000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $18.7M | $14.9M | $9.6M | $19.8M | $9.2M | $19.7M | $21.8M | $9.8M | $5.3M | $15.2M |
| Property, Plant & Equipment | $1.2M | $3.1M | $2.3M | $3.0M | $2.5M | $1.8M | $1.6M | $1.1M | $521000 | $327000 |
| Goodwill | $3.9M | $3.9M | $372000 | $372000 | $372000 | $372000 | $372000 | $372000 | $372000 | $372000 |
| Intangible Assets | $8.4M | $7.2M | 0 | 0 | $86000 | $51000 | $94000 | $42000 | $469000 | $333000 |
| Total Assets | $34.6M | $31.6M | $24.0M | $23.2M | $12.1M | $22.0M | $23.9M | $11.4M | $6.6M | $16.3M |
| Accounts Payable | $1.3M | $1.3M | $721000 | $327000 | $789000 | $2.6M | $8.4M | $4.8M | $9.5M | $3.3M |
| Short-term Debt | $6.6M | $13.6M | $14.2M | $11.1M | $6.3M | $1.6M | $1.7M | $4.0M | $3.3M | $806000 |
| Total Current Liabilities | $12.5M | $18.4M | $17.6M | $14.5M | $8.5M | $5.9M | $11.9M | $10.7M | $15.6M | $12.3M |
| Long-term Debt | $11.0M | 0 | 0 | 0 | 0 | $5.0M | $3.8M | 0 | 0 | $15000 |
| Total Liabilities | $23.6M | $18.6M | $18.8M | $22.1M | $9.1M | $11.1M | $17.4M | $12.7M | $15.6M | $12.3M |
| Retained Earnings | -$379.1M | -$401.7M | -$414.4M | -$425.3M | -$433.5M | -$446.9M | -$467.2M | -$480.5M | -$493.5M | -$515.9M |
| Total Equity | $11.0M | $13.0M | $5.2M | $1.2M | $3.0M | $10.8M | $6.4M | -$1.3M | -$8.9M | $4.0M |
| Total Debt | $17.6M | $13.6M | $14.2M | $12.0M | $7.0M | $7.0M | $5.8M | $4.2M | $3.4M | $821000 |
| Net Debt | $5.1M | $4.1M | $8.9M | -$5.6M | -$1.4M | -$11.4M | -$12.4M | -$4.4M | -$239000 | -$7.9M |
| Working Capital | $6.2M | -$3.5M | -$7.9M | $5.3M | $636000 | $13.9M | $10.0M | -$893000 | -$10.3M | $2.9M |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 1.37 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -44.86 |
Profitability
| Return on Equity | -560.21% |
| Return on Invested Capital | -317.58% |
| Return on Assets | -137.13% |
| Gross Margin | 61.53% |
| Operating Margin | -628.12% |
| Net Margin | -620.70% |
Related companies: ADTX · BXRXQ · EDSA · MTVA · PHIO · RKTO
Explore sector: Healthcare · Biotechnology
More sections of PSTV: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks